OCGN has been granted a new patent
Dec 25, 2024, 11:35 PM
8.59%
What does OCGN do
Ocugen is a biopharmaceutical company based in Malvern, Pennsylvania, focused on gene and cell therapies for eye diseases, including inherited retinal disorders. The company also develops inhalation-based vaccines for COVID-19 and seasonal flu.
OCGN filed a patent for "multicistronic vaccine and methods for producing and using the same" on Thu, February 23, 2023.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.